Clinical Edge

Summaries of Must-Read Clinical Literature, Guidelines, and FDA Actions

MI Alert Device Has Predictive Value

Key clinical point: In a new trial analysis, an implantable alert device relative to a sham identified silent MIs and avoided false positive ER visits.

Major finding: False-positive ER visits fell from 0.678 when device was off to 0.164/year (P less than .001) when device was activated.

Data source: ALERTS, a multicenter, randomized controlled trial

Disclosures: Dr. Gibson has financial relationships with many companies, including Angel Medical Systems, the sponsor of this trial.

Citation:

REPORTING FROM CRT 2019